Last10K.com

Assembly Biosciences, Inc. (ASMB) SEC Filing 8-K Material Event for the period ending Thursday, January 11, 2024

Assembly Biosciences, Inc.

HISTORY TOOLS
CIK: 1426800 Ticker: ASMB

View differences made from one to another to evaluate Assembly Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Assembly Biosciences, Inc..

Continue

Assess how Assembly Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Assembly Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information
Ticker: ASMB
CIK: 1426800
Form Type: 8-K Corporate News
Accession Number: 0000950170-24-005024
Submitted to the SEC: Wed Jan 17 2024 4:05:09 PM EST
Accepted by the SEC: Wed Jan 17 2024
Period: Thursday, January 11, 2024
Industry: Pharmaceutical Preparations
Events:
  1. Ending Agreement

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/asmb/0000950170-24-005024.htm